Genomics

Ultima Genomics & Gene by Gene Expand Global UG 100 Sequencing

Ultima Genomics & Gene by Gene Expand Global UG 100 Sequencing

Collaboration Extends Global Reach of High-Performance Genomic Sequencing on the UG 100â„¢ Platform

Ultima Genomics, Inc., developer of the UG 100™ next-generation sequencing (NGS) platform, and Gene by Gene, a leading global provider of advanced genetic testing and genomic services, today announced a partnership to broaden worldwide access to high-quality, cost-effective DNA sequencing.

Through this collaboration, Gene by Gene will join Ultima’s growing network of Certified Service Providers—offering whole genome sequencing and other genomic applications on the UG 100. Leveraging Ultima’s scalable sequencing architecture, Gene by Gene will deliver industry-leading DNA analysis services for clinical, research, direct-to-consumer (DTC), and forensic applications. They will join current Certified Service Provider partners including Broad Clinical Labs, Inocras, Macrogen, New York Genome Center, Ontario Institute for Cancer Research, Novogene, Psomagen, and the University of Minnesota Genomics Center.

“Ultima Genomics’ unique sequencing platform architecture supports a range of genomics applications by providing cost-effective sequencing at unprecedented scale,” said Jay Therrien, PhD, Chief Commercial Officer of Ultima Genomics. “We are excited to partner with Gene by Gene to expand access to the UG 100 for researchers and organizations around the world.”

“Gene by Gene has always been committed to making advanced genetic testing more accessible without compromising quality,” said Josh Wittner, President of Gene by Gene. “Partnering with Ultima allows us to harness the power of the UG 100 to deliver exceptional sequencing output and affordability to our clients globally. It opens new opportunities for discovery, innovation, and impact.”

The collaboration will leverage the UG 100 sequencing platform and UG 100 Solarisâ„¢, Ultima’s recently launched chemistry, improved software, and simplified workflows.  Solaris provides a more than 50% increase in sequencing output per run over the prior chemistry—up to 10 to 12 billion reads per wafer—while reducing sequencing costs and enabling simplified workflows for customers. 

Explore AITechPark for the latest advancements in AI, IOT, Cybersecurity, AITech News, and insightful updates from industry experts!

PR Newswire

PR Newswire empowers communicators to identify and engage with key influencers, craft and distribute meaningful stories, and measure the financial impact of their efforts. Cision is a leading global provider of earned media software and services to public relations and marketing communications professionals.

Related posts

InterVenn Biosciences Expands Board of Directors

Business Wire

Contactile Raises US$2.5 Million to Accelerate Development

PR Newswire

Genomic Healthcare AI Imaging Provider EchelonDx & Oncocyte Collab

Business Wire